Athenex, Inc. (NASDAQ:ATNX)

About the company

Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel therapies for the treatment of cancer. It operates through the following segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Global Supply Chain Platform segment provides supply of active pharmaceutical ingredients (APIs) for clinical and commercial efforts. The Commercial Platform segment involves in the sales and marketing of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

574

CEO

Yiu Nam Lau

Exchange

NASDAQ

Website

http://www.athenex.com

$141.00M

Total Revenue

574

Employees

$954.40M

Market Capitalization

-8.28

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$56M

Operating Margin (in %)

Total operating margin

$-103M

Net Margin (in %)

Total net margin

$-117M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 385799.25 80503.00 6.04 25.38 18.86
Merck & Co., Inc. MRK 211643.70 47194.00 7.58 20.17 22.20
Pfizer Inc. PFE 201257.27 49197.00 3.09 14.13 28.80
Eli Lilly & Co. LLY 136012.34 22949.00 34.77 24.00 24.48
AbbVie, Inc. ABBV 133062.78 36227.00 10.46 19.07 19.06
Bristol Myers Squibb Co. BMY 117513.44 34862.00 2.67 -200.21 -1.61
Royalty Pharma Plc RPRX 25360.46 1922.00 6.10 36.02 36.50
Repligen Corp. RGEN 7403.76 302.00 6.80 249.79 10.23
Allakos, Inc. ALLK 3768.48 None 8.59 -33.27 None
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3423.75 11.00 -105.51 -5.68 None
Reata Pharmaceuticals, Inc. RETA 3287.68 15.00 14.91 -9.40 -150.30
Nektar Therapeutics NKTR 3191.31 163.00 2.57 -7.42 -264.25
Principia Biopharma, Inc. PRNB 2998.50 50.00 9.46 -40.47 -137.82
Turning Point Therapeutics, Inc. TPTX 2953.44 None 4.87 -25.09 None
ADC Therapeutics SA ADCT 2425.36 2.00 12.29 -10.20 None
IGM Biosciences, Inc. IGMS 2355.38 None 11.26 -37.80 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Apellis Pharmaceuticals, Inc. APLS 2085.18 None 9.84 -4.48 None
Zymeworks, Inc. ZYME 2071.60 30.00 4.09 -11.24 -569.13
Springworks Therapeutics, Inc. SWTX 1932.85 None 6.65 -28.27 None
OPKO Health, Inc. OPK 1921.96 966.00 1.30 -9.35 -20.69
Karuna Therapeutics, Inc. KRTX 1903.50 None 5.45 0.15 None
Forma Therapeutics Holdings, Inc. FMTX 1878.80 11.00 4.25 -33.36 -513.80
Akcea Therapeutics, Inc. AKCA 1814.50 337.00 3.85 -49.04 -12.34
Y-mAbs Therapeutics, Inc. YMAB 1635.14 None 11.79 -14.44 None
Y-mAbs Therapeutics, Inc. YMAB 1587.64 None 11.45 -14.02 None
Generation Bio Co. GBIO 1236.15 0.00 4.19 -18.31 None
Repare Therapeutics, Inc. RPTX 1187.70 None 3.76 -30.28 None
Athenex, Inc. ATNX 954.40 141.00 7.85 -8.28 -82.63
Arcutis Biotherapeutics, Inc. ARQT 936.70 None 4.51 -10.27 None
Phathom Pharmaceuticals, Inc. PHAT 903.24 None 4.72 -4.29 None
Akero Therapeutics, Inc. AKRO 901.04 None 10.76 9.44 None
Quanterix Corp. QTRX 884.24 60.00 8.95 -19.74 -74.92
Kiniksa Pharmaceuticals Ltd. KNSA 882.00 None 4.27 -7.22 None
Keros Therapeutics, Inc. KROS 823.00 5.00 5.87 -28.58 -581.22
Krystal Biotech, Inc. KRYS 745.74 None 2.63 -33.68 None
Annexon, Inc. ANNX 725.25 None -7.57 -19.18 None
Phibro Animal Health Corp. PAHC 721.60 800.00 3.78 21.20 4.19
Gossamer Bio, Inc. GOSS 711.90 None 1.93 -3.16 None
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Constellation Pharmaceuticals, Inc. CNST 634.32 None 1.77 -6.32 None
Arcturus Therapeutics Holdings, Inc. ARCT 582.60 11.00 10.14 -14.88 -341.76
SIGA Technologies, Inc. SIGA 579.74 55.00 5.84 117.83 11.35
Oric Pharmaceuticals, Inc. ORIC 576.90 None 3.01 -16.58 None
Amneal Pharmaceuticals, Inc. AMRX 550.25 1739.00 1.87 -2.52 -11.16
Fusion Pharmaceuticals, Inc. FUSN 515.34 None 1.62 -7.87 None
Ocular Therapeutix, Inc. OCUL 492.66 7.00 97.75 -3.93 None
Nurix Therapeutics, Inc. NRIX 472.32 19.00 10.25 -22.71 -106.51
Mirum Pharmaceuticals, Inc. MIRM 467.00 None 3.49 -6.03 None
Tricida, Inc. TCDA 466.50 None 2.02 -1.97 None
Aprea Therapeutics, Inc. APRE 464.31 None 4.67 -10.38 None
Oyster Point Pharma, Inc. OYST 464.10 None 2.08 -7.26 None
G1 Therapeutics, Inc. GTHX 459.42 2.00 2.26 -3.49 None
TCR2 Therapeutics, Inc. TCRR 452.88 None 4.72 -9.30 None
Odonate Therapeutics, Inc. ODT 449.81 None 5.30 -3.81 None
Inozyme Pharma, Inc. INZY 448.00 None -10.47 -16.35 None
Applied Therapeutics, Inc. APLT 388.74 14.00 3.53 -5.57 -19.41
Biospecifics Technologies Corp. BSTC 376.25 35.00 3.05 21.67 52.45
Imara, Inc. IMRA 359.72 None 3.45 -9.36 None
Crinetics Pharmaceuticals, Inc. CRNX 354.12 1.00 2.21 -5.65 -447.78
Relmada Therapeutics, Inc. RLMD 338.22 0.00 4.56 -28.26 -877.66
89bio, Inc. ETNB 335.58 None 5.79 -5.49 None
DURECT Corp. DRRX 330.34 50.00 9.22 -166.00 -3.66
Kala Pharmaceuticals, Inc. KALA 327.18 5.00 3.47 -3.55 None
AMAG Pharmaceuticals, Inc. AMAG 312.12 298.00 1.27 -1.20 -86.95
TFF Pharmaceuticals, Inc. TFFP 310.08 None 16.32 -7.73 None
Urovant Sciences Ltd. UROV 283.03 None -3.36 -1.87 None
Ovid Therapeutics, Inc. OVID 279.75 None 11.66 -3.66 None
Sutro Biopharma, Inc. STRO 273.00 40.00 1.82 -12.35 -43.34
Osmotica Pharmaceuticals Plc OSMT 263.45 212.00 2.34 -1.63 -73.47
HOOKIPA Pharma, Inc. HOOK 248.30 16.00 2.36 -9.46 -247.22
Aquestive Therapeutics, Inc. AQST 240.60 59.00 -12.53 -4.56 -84.20
IDEAYA Biosciences, Inc. IDYA 236.40 None 1.99 -53.73 None
KalVista Pharmaceuticals, Inc. KALV 231.21 9.00 3.09 -7.02 -349.66
Lannett Co., Inc. LCI 226.59 546.00 0.77 -6.76 -6.11
Fulcrum Therapeutics, Inc. FULC 217.35 3.00 1.81 -3.25 None
Cyclerion Therapeutics, Inc. CYCN 203.56 5.00 3.73 -2.15 None
Galera Therapeutics, Inc. GRTX 199.00 None 4.91 -2.81 None
Verrica Pharmaceuticals, Inc. VRCA 198.25 None 4.22 -6.01 None
Xeris Pharmaceuticals, Inc. XERS 185.69 6.00 11.30 -1.51 None
Milestone Pharmaceuticals, Inc. MIST 179.25 None 2.01 -5.88 None
Immunic, Inc. IMUX 178.20 None 4.26 -6.18 None
Avenue Therapeutics, Inc. ATXI 177.12 532.00 44.28 -17.57 26.69
Spero Therapeutics, Inc. SPRO 176.70 12.00 3.27 -2.13 -713.29
Veru, Inc. VERU 176.22 40.00 4.53 -16.69 -25.78
LogicBio Therapeutics, Inc. LOGC 161.00 2.00 5.88 -4.00 None
Kaleido Biosciences, Inc. KLDO 157.79 0.00 3.53 -2.04 None
Ayala Pharmaceuticals, Inc. AYLA 156.39 3.00 2.85 -6.40 -728.78
Eton Pharmaceuticals, Inc. ETON 152.95 1.00 23.68 -7.19 None
Harrow Health, Inc. HROW 151.58 45.00 9.56 -6.78 -48.54
Lyra Therapeutics, Inc. LYRA 148.85 1.00 1.70 -8.42 -491.16
scPharmaceuticals, Inc. SCPH 142.80 119.00 1.99 -4.41 -27.05
NeuBase Therapeutics, Inc. NBSE 142.38 None 5.27 -2.65 None
Evelo Biosciences, Inc. EVLO 134.56 None 2.80 -1.54 None
Mustang Bio, Inc. MBIO 131.88 None 2.49 -2.45 None
Checkpoint Therapeutics, Inc. CKPT 123.30 1.00 10.96 -5.27 -873.97
Liquidia Technologies, Inc. LQDA 117.36 8.00 21.26 -1.98 -589.48
Evolus, Inc. EOLS 113.77 51.00 2.84 -1.40 -161.74
Lantern Pharma, Inc. LTRN 113.28 None 5.05 -43.91 None
Corvus Pharmaceuticals, Inc. CRVS 112.52 None 2.14 -2.50 None
Tyme Technologies, Inc. TYME 109.99 None 7.77 -4.05 None
Protara Therapeutics, Inc. TARA 101.16 None 1.66 -3.37 None
Gritstone Oncology, Inc. GRTS 100.08 4.00 1.09 -0.94 None
PhaseBio Pharmaceuticals, Inc. PHAS 89.55 1.00 3.43 -1.34 None
Genprex, Inc. GNPX 81.60 None 5.40 -5.76 None
Menlo Therapeutics, Inc. MNLO 76.95 13.00 3.14 -0.35 -483.51
Satsuma Pharmaceuticals, Inc. STSA 73.61 None 0.80 -1.80 None
Trevi Therapeutics, Inc. TRVI 69.30 None 1.76 -4.53 None
Edesa Biotech, Inc. EDSA 67.14 0.00 13.32 -0.71 -395.23
Clearside Biomedical, Inc. CLSD 65.79 7.00 9.56 -3.73 -280.03
BiomX, Inc. PHGE 64.57 None 1.85 -1.51 None
Aerpio Pharmaceuticals, Inc. ARPO 62.32 15.00 1.50 -16.89 -24.91
EyePoint Pharmaceuticals, Inc. EYPT 61.56 23.00 18.00 -1.17 -229.33
Aridis Pharmaceuticals, Inc. ARDS 59.58 1.00 -9.74 -2.47 -851.00
Baudax Bio, Inc. BXRX 56.52 0.00 -0.97 -0.65 None
Assertio Holdings, Inc. ASRT 56.28 156.00 0.85 -0.26 -117.10
Navidea Biopharmaceuticals, Inc. NAVB 55.00 1.00 -30.56 -5.29 -65.13
Eyenovia, Inc. EYEN 52.92 None 8.65 -2.70 None
Adamis Pharmaceuticals Corp. ADMP 48.10 20.00 2.39 -1.45 -170.82
Moleculin Biotech, Inc. MBRX 41.00 None 3.28 -2.16 None
ProPhase Labs, Inc. PRPH 39.84 11.00 3.53 -23.71 -14.31
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Aileron Therapeutics, Inc. ALRN 35.38 None 2.90 -1.36 None
Mannatech, Inc. MTEX 32.96 153.00 1.40 8.77 2.96
Annovis Bio, Inc. ANVS 31.57 None 3.27 -9.60 None
AgeX Therapeutics, Inc. AGE 31.54 2.00 -13.83 -2.59 -625.09
Citius Pharmaceuticals, Inc. CTXR 31.17 None 1.87 -1.80 None
Allena Pharmaceuticals, Inc. ALNA 30.25 None 2.52 -0.76 None
Oncternal Therapeutics, Inc. ONCT 28.64 2.00 4.07 2.11 -778.44
CNS Pharmaceuticals, Inc. CNSP 27.00 None 7.83 -3.60 None
Acer Therapeutics, Inc. ACER 24.60 3.00 2.62 -1.18 -274.69
Millendo Therapeutics, Inc. MLND 24.56 0.00 0.66 -0.52 None
Spring Bank Pharmaceuticals, Inc. SBPH 22.95 0.00 1.00 -0.77 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Novan, Inc. NOVN 22.57 5.00 -0.51 -0.62 -572.98
Hoth Therapeutics, Inc. HOTH 22.55 None 4.02 -2.11 None
Sun BioPharma, Inc. SNBP 21.00 1.00 17.65 -4.55 -7.89
Daré Bioscience, Inc. DARE 20.77 1.00 98.90 -1.16 None
PDS Biotechnology Corp. PDSB 20.34 None 2.97 -0.86 None
Novus Therapeutics, Inc. NVUS 14.54 None 2.42 -0.85 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Adial Pharmaceuticals, Inc. ADIL 13.20 None 1.85 -1.64 None
Titan Pharmaceuticals, Inc. TTNP 11.59 5.00 9.50 -1.73 -351.69
Brickell Biotech, Inc. BBI 5.46 10.00 1.08 -0.24 -165.28
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Athenex Announces FDA Allowance of IND Application for TCRT-ESO-A2, a TCR-T Cell Therapy

1d ago, source: Business Insider

23, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of ...

FDA OKs Athenex IND application for TCRT-ESO-A2

1d ago, source: Seeking Alpha

Athenex (NASDAQ:ATNX) announced that the USFDA has allowed its investigational new drug application for TCRT-ESO-A2, an autologous T cell receptor (TCR)-T cell therapy targeting solid tumors that are ...

Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $112,200 of Shares

12d ago, source: YAHOO!

CEO and Chairman of the Board of Athenex Inc (30-Year Financial, Insider Trades) Johnson Yiu Nam Lau (insider trades) bought 10,000 shares of ATNX on 09/10/2020 at an average price of $11.22 a share.

Athenex, Inc. Announces Pricing of $110 Million Public Offering of Common Stock

13d ago, source: Nasdaq

BUFFALO, N.Y., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and ...

Athenex, Inc. Announces Proposed Public Offering of Common Stock

16d ago, source: MarketWatch

08, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of ...

61 Biggest Movers From Yesterday

13d ago, source: Benzinga on MSN.com

Gainers Yield10 Bioscience Inc (NASDAQ: YTEN) shares jumped 53.8% to close at $6.69 on Thursday after HC Wainwright & Co. initiated coverage on the company's stock with a Buy rating and announced a ...

Athenex, Inc. Announces Pricing of $110 Million Public Offering of Common Stock

14d ago, source: MarketWatch

10, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.